Glenn McEnroe

2.3k total citations · 1 hit paper
20 papers, 1.8k citations indexed

About

Glenn McEnroe is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Glenn McEnroe has authored 20 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Oncology. Recurrent topics in Glenn McEnroe's work include Receptor Mechanisms and Signaling (6 papers), Heart Failure Treatment and Management (5 papers) and Chemical Synthesis and Analysis (4 papers). Glenn McEnroe is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Heart Failure Treatment and Management (5 papers) and Chemical Synthesis and Analysis (4 papers). Glenn McEnroe collaborates with scholars based in United States, Netherlands and Germany. Glenn McEnroe's co-authors include Robert M. Scarborough, John Lewicki, Thomas Maack, Daniel R. Nussenzveig, Fernando Antônio de Almeida, Muneya Suzuki, J G Porter, Andrew A. Protter, Dale B. Schenk and Sven Krämer and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Glenn McEnroe

20 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Physiological Role of Silent Receptors of Atrial Natriuretic Factor

1987 786 citations Thomas Maack, Muneya Suzuki et al. Science profile →

Peers

Countries citing papers authored by Glenn McEnroe

Since Specialization

Citations

This map shows the geographic impact of Glenn McEnroe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn McEnroe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn McEnroe more than expected).

Fields of papers citing papers by Glenn McEnroe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn McEnroe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn McEnroe. The network helps show where Glenn McEnroe may publish in the future.

Co-authorship network of co-authors of Glenn McEnroe

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn McEnroe. A scholar is included among the top collaborators of Glenn McEnroe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn McEnroe. Glenn McEnroe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of Mutations in the mrdA Gene Encoding PBP2 That Reduce Carbapenem and Diazabicyclooctane Susceptibility of Escherichia coli Clinical Isolates with Mutations in ftsI (PBP3) and Which Carry bla _NDM-1 2019 ·mSphere ·(unknown), Folkert Reck, Xiaobo Ke, (unknown), Glenn McEnroe, Sara López, Charles R. Dean	23
2	Synthesis and Microbiological Evaluation of Novel Tetracyclic Fluoroquinolones 2017 ·ChemMedChem ·Allan S. Wagman, Ryan T. Cirz, Glenn McEnroe, James B. Aggen, Martin S. Linsell, (unknown), Sara López, Marcela Gómez, (unknown), (unknown), Thomas R. Belliotti, Christina R. Harris, (unknown), (unknown), R.D. Gaston, Heinz E. Moser	20
3	Selective inhibitors of type I receptor kinase block cellular transforming growth factor-β signaling 2004 ·Biochemical Pharmacology ·Rongrong Ge, (unknown), (unknown), Kim A. Reiss, David Liu, Linda S. Higgins, Alison Joly, Sundeep Dugar, (unknown), Margaret Henson, Glenn McEnroe, George F. Schreiner, Michael Reiß	28
4	Targeting Endogenous Transforming Growth Factor β Receptor Signaling in SMAD4-Deficient Human Pancreatic Carcinoma Cells Inhibits Their Invasive Phenotype 2004 ·Cancer Research ·Gayathri Subramanian, Roderich E. Schwarz, Linda S. Higgins, Glenn McEnroe, Sarvajit Chakravarty, Sundeep Dugar, Michael Reiß	112
5	TGF-β Receptor I Kinase Inhibitor Downregulates Cytokine Secretion and Multiple Myeloma Cell Growth in the Bone Marrow Microenvironment. 2004 ·Blood ·Toshiaki Hayashi, Teru Hideshima, Klaus Podar, Paul G. Richardson, Oscar Muñoz, Makoto Hamasaki, Kenji Ishitsuka, Hiroshi Yasui, Alison Murphy, Glenn McEnroe, Sarvajit Chakravarty, Sundeep Dugar, Linda S. Higgins, Dharminder Chauhan, Kenneth C. Anderson	6
6	Peptides Derived from the Complementarity-determining Regions of Anti-Mac-1 Antibodies Block Intercellular Adhesion Molecule-1 Interaction with Mac-1 1998 ·Journal of Biological Chemistry ·Yingqing Feng, (unknown), Lisa J. Garrard, Glenn McEnroe, (unknown), (unknown), (unknown), Andrew W. Guzzetta, Andrew Lam, Judith A. Abraham, David Liu, Gerda Endemann	25
7	Solid phase synthesis of combinatorial libraries using anhydrides as templates 1997 ·Molecular Diversity ·John Perumattam, Sarvajit Chakravarty, Glenn McEnroe, R. Richard Goehring, Babu Mavunkel, (unknown), Whitney W. Smith, Baili Chen	5
8	A peptide derived from neutrophil inhibitory factor (NIF) blocks neutrophil adherence to endothelial cells 1997 ·Inflammation Research ·K P Madden, Jan Janczak, Glenn McEnroe, (unknown), Thomas G. Hartman, (unknown), Lawrence W. Stanton	5
9	Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin. 1994 ·Journal of Biological Chemistry ·Stuart A. Thompson, Shigeki Higashiyama, Kathleen M. Wood, N. Stephen Pollitt, Deborah Damm, Glenn McEnroe, (unknown), (unknown), (unknown), Nancy C. Hancock	141
10	C-type natriuretic peptides stimulate chloride secretion in the rectal gland of Squalus acanthias 1992 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Richard Solomon, Andrew A. Protter, Glenn McEnroe, J Porter, (unknown)	36
11	C-type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells 1992 ·American Journal of Physiology-Cell Physiology ·J G Porter, (unknown), Glenn McEnroe, John Lewicki, Andrew A. Protter	98
12	Effects of small C-ANF receptor ligands on plasma levels of atrial natriuretic factor, blood pressure, and renal function in the rat 1991 ·Canadian Journal of Physiology and Pharmacology ·J Okolicány, Glenn McEnroe, (unknown), John Lewicki, Thomas Maack	8
13	Dehydration increases the density of C receptors for ANF on rat glomerular membranes 1990 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·(unknown), Angelika M. Vollmar, Glenn McEnroe, Alexander L. Gerbes	28
14	Recombinant Expression of a Secreted form of the Atrial Natriuretic Peptide Clearance Receptor 1989 ·Journal of Biological Chemistry ·J G Porter, Robert M. Scarborough, Yingfei Wang, Dale Schenk, Glenn McEnroe, (unknown), John Lewicki	20
15	D-amino acid-substituted atrial natriuretic peptide analogs reveal novel receptor recognition requirements. 1988 ·Journal of Biological Chemistry ·Robert M. Scarborough, Glenn McEnroe, Ann Arfsten, (unknown), Karen Schwartz, John Lewicki	25
16	Physiological Role of Silent Receptors of Atrial Natriuretic Factor breakdown → 1987 ·Science ·Thomas Maack, Muneya Suzuki, Fernando Antônio de Almeida, Daniel R. Nussenzveig, Robert M. Scarborough, Glenn McEnroe, John Lewicki	786
17	Truncated atrial natriuretic peptide analogs. Comparison between receptor binding and stimulation of cyclic GMP accumulation in cultured vascular smooth muscle cells. 1986 ·Journal of Biological Chemistry ·Robert M. Scarborough, Dale B. Schenk, Glenn McEnroe, Ann Arfsten, (unknown), Karen Schwartz, John Lewicki	130
18	Isolation of a cDNA clone encoding the amino-terminal region of human apolipoprotein B. 1986 ·Proceedings of the National Academy of Sciences ·Andrew A. Protter, D A Hardman, James W. Schilling, Judith Miller, (unknown), (unknown), (unknown), Glenn McEnroe, John P. Kane	47
19	Identification of the receptor for atrial natriuretic factor on cultured vascular cells. 1985 ·Journal of Biological Chemistry ·Dale B. Schenk, (unknown), J G Porter, Robert M. Scarborough, Glenn McEnroe, John Lewicki	78
20	Isolation and primary structure of two peptides with cardioacceleratory and hyperglycemic activity from the corpora cardiaca of Periplaneta americana. 1984 ·Proceedings of the National Academy of Sciences ·Robert M. Scarborough, Gene C. Jamieson, (unknown), Sven Krämer, Glenn McEnroe, Charles A. Miller, David A. Schooley	216

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact